| Are methamphetamine precursor control laws effective tools to fight the methamphetamine epidemic? | |
| | |
MedLine Citation:
|
PMID: 21433216 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
One of the most notable trends in illegal substance use among Americans over the past decade is the dramatic growth and spread of methamphetamine use. In response to the dramatic rise in methamphetamine use and its associated burden, a broad range of legislations has been passed to combat the problem. In this paper, we assess the impact of retail-level laws intended to restrict chemicals used to manufacture methamphetamine (methamphetamine precursor laws) in reducing indicators of domestic production, methamphetamine availability, and the consequences of methamphetamine use. Specifically, we examine trends in these indicators of methamphetamine supply and use over a period spanning the implementation of the federal Methamphetamine Anti-Proliferation Act (MAPA) (October 2000) and a more stringent state-level restriction enacted in California (January 2000). The results are mixed in terms of the effectiveness of legislative efforts to control methamphetamine production and use, depending on the strength of the legislation (California Uniform Controlled Substances Act versus federal MAPA), the specification of the comparison group, and the particular outcome of interest. Some evidence suggests that domestic production was impacted by these legislative efforts, but there is also evidence that prices fell, purities rose, and treatment episodes increased. Copyright © 2010 John Wiley & Sons, Ltd. |
| | |
Authors:
|
James Nonnemaker; Mark Engelen; Daniel Shive |
Related Documents
:
|
22275966 - 2007 eortc-nci-asco annual meeting: molecular markers in cancer. 21528736 - What makes a real man? gender norms and western australia v. ah [2010] wasca 172. 21345576 - Primary immunodeficiency diseases in latin america: proceedings of the second latin ame... 21473176 - Mysteries of nature. 20725266 - Analysis of the holographic reciprocity law for dichromated gelatin. 17244066 - Ethics and the sexual countertransference. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Health economics Volume: 20 ISSN: 1099-1050 ISO Abbreviation: Health Econ Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-03-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9306780 Medline TA: Health Econ Country: England |
Other Details:
|
Languages: eng Pagination: 519-31 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 John Wiley & Sons, Ltd. |
Affiliation:
|
RTI International, Research Triangle Park, NC, USA. jnonnemaker@rti.org. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Simultaneous relationships between procedure volume and mortality: do they bias studies of mortality...
Next Document: Cumulative effects of job characteristics on health.